Scinai Immunotherapeutics Ltd. Share Price
Stocks
SCNI
US09073Q4029
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
01:30:00 31/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.4716 USD | -9.05% |
|
-16.46% | -93.38% |
| 16/10 | Scinai Immunotherapeutics Ltd. announced that it has received $2.95 million in funding | CI |
| 14/10 | Scinai Immunotherapeutics Ltd. announced that it expects to receive $2.95 million in funding | CI |
| Market Cap | 3L 2L 2L 2L 4L 2.55Cr 4L 26.41L 10.6L 1.34Cr 10.09L 10L 4.23Cr | P/E 2024 * |
-
| P/E 2025 | -0.2x |
|---|---|---|---|---|---|
| Enterprise Value | 9L 8L 7L 7L 12.21L 8.31Cr 12.43L 85.94L 34.5L 4.37Cr 32.83L 32.13L 14Cr | EV / Sales 2024 |
45,21,658x | EV / Sales 2025 | 23,46,086x |
| Free-Float |
0.36% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SCNI | Delayed | |
CBOE
| SCNI | Real-time | |
|
Deutsche Boerse AG
| 2F50 | Delayed |
Last Transcript: Scinai Immunotherapeutics Ltd.
| 1 day | -9.05% | ||
| 1 week | -16.46% | ||
| 1 month | -66.79% | ||
| 3 months | -82.73% | ||
| 6 months | -93.63% | ||
| Current year | -93.38% |
| 1 week | 0.47 |  | 0.57 |
| 1 month | 0.47 | | 1.76 |
| Current year | 0.47 | | 11.2 |
| 1 year | 0.47 | | 15.5 |
| 3 years | 0.47 | | 89.2 |
| 5 years | 0.47 | | 3,490 |
| 10 years | 0.47 | | 61,999.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Amir Reichman
CEO | Chief Executive Officer | 51 | 02/03/2021 |
Uri Ben-Or
DFI | Director of Finance/CFO | 55 | 01/01/2007 |
Dalit Fischer
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Germain
CHM | Chairman | 77 | 30/09/2019 |
Samuel Moed
BRD | Director/Board Member | 64 | 24/03/2020 |
Adi Raviv
BRD | Director/Board Member | 71 | 24/03/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/03/26 | Other | Chief Financial Officer | 3,58,48,348 | 1.0507% | ||
| 18/03/26 | Other | Director | 5,74,00,000 | 1.6823% | ||
| 18/03/26 | Other | Director | 6,04,00,000 | 1.7702% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -9.05% | -16.46% | -96.63% | -99.29% | 3L | |
| -0.62% | -1.87% | +42.87% | +64.15% | 6.38TCr | |
| +0.35% | +3.20% | +14.40% | +81.76% | 5.64TCr | |
| +0.53% | +1.96% | +16.24% | +103.35% | 5.46TCr | |
| -2.81% | -4.31% | +23.50% | +47.83% | 4.41TCr | |
| -0.33% | -1.93% | +19.28% | +98.80% | 4.21TCr | |
| +0.55% | +2.31% | +225.14% | +866.21% | 4.1TCr | |
| +3.27% | +47.96% | +112.84% | +96.58% | 3.49TCr | |
| +1.22% | -1.44% | +14.57% | +46.95% | 3.28TCr | |
| +0.89% | +20.55% | -40.62% | +349.24% | 2.47TCr | |
| Average | -0.60% | +5.14% | +33.16% | +165.56% | 3.94TCr | |
| Weighted average by Cap. | +0.18% | +5.44% | +47.99% | +176.67% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.66 0.59 0.54 0.49 0.92 62.48 0.94 6.46 2.59 32.86 2.47 2.42 103.64 | 1.31 1.17 1.08 0.98 1.83 124.48 1.86 12.88 5.17 65.48 4.92 4.82 206.5 |
| Net income | 47.96L 42.95L 39.51L 35.8L 66.92L 46Cr 68.17L 4.71Cr 1.89Cr 24Cr 1.8Cr 1.76Cr 76Cr | -83.07L -74.4L -68.43L -62.01L -1.16Cr -79Cr -1.18Cr -8.16Cr -3.28Cr -41Cr -3.12Cr -3.05Cr -130.85Cr |
| Net Debt | 1L 1L 1L 91.07T 2L 1.16Cr 2L 11.99L 5L 60.94L 5L 4L 1.92Cr | 6L 5L 5L 5L 8L 5.75Cr 9L 59.53L 23.9L 3.03Cr 22.74L 22.26L 9.55Cr |
Employees
45
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/26/30 | $0.4716 | -9.05% | 52,954 |
| 29/26/29 | $0.5185 | -2.92% | 46,011 |
| 28/26/28 | $0.5341 | +0.58% | 39,406 |
| 27/26/27 | $0.5310 | -1.94% | 50,187 |
| 26/26/26 | $0.5415 | -4.07% | 1,22,313 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SCNI Stock
Select your edition
All financial news and data tailored to specific country editions
